RTW Funds

RTW Funds is a life sciences investment and innovation firm specializing in biotechnology and pharmaceutical sectors. The firm invests across the full lifecycle of companies, including company creation, early-stage venture capital, crossover, and public company investments. With a team comprising scientists, entrepreneurs, and investors, RTW Funds is headquartered in New York, with offices in London and Shanghai. As of July 2022, the firm has invested in 70 private companies.

RTW Funds focuses on identifying and investing in transformative assets with significant growth potential across the life sciences, biopharmaceutical, and medical technology sectors. The firm's investment strategy encompasses various stages, from seed and early-stage investments to growth, late-stage, and pre-IPO funding. Geographically, RTW Funds has a core focus on the United States, with deep coverage of opportunities from academia to mid-size public companies, and also invests in the United Kingdom and China.

The firm's mission is to power breakthrough therapies by supporting scientists and entrepreneurs to identify opportunities for their companies. RTW Funds partners with companies at all stages of development, from early-stage ventures to multi-product public companies, providing both financial support and expertise to drive success. The firm aims to make a major difference in patients' lives by investing for the long term and powering the next generation of breakthroughs in science and medicine to help transform lives.